Samsung planned $22B investment includes biopharma, AI

Samsung Group (Seoul, South Korea) said it would invest W25

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE